Bionomics Limited, (BNOX) Social Stream
BIONOMICS LIMITED (BNOX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BNOX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-10 | 5 | $54 | $17 | $36 | $1.13 | 3085.84% |
| 2022-03-02 | 5 | $54 | $17 | $33 | $1.13 | 2820.35% |
| 2022-10-13 | 5 | $54 | $17 | $33 | $1.13 | 2820.35% |
| 2022-11-01 | 6 | $54 | $17 | $31 | $1.13 | 2643.36% |
| 2022-12-20 | 6 | $40 | $6 | $22.5 | $1.13 | 1891.15% |
| 2023-01-18 | 5 | $23 | $6 | $13 | $1.13 | 1050.44% |
| 2023-03-10 | 5 | $17 | $6 | $10.333 | $1.13 | 814.42% |
| 2023-06-23 | 5 | $17 | $6 | $10 | $1.13 | 784.96% |
| 2023-09-28 | 5 | $17 | $6 | $9.5 | $1.13 | 740.71% |
| 2023-10-16 | 4 | $10 | $6 | $8 | $1.13 | 607.96% |
The Trend in the Analyst Price Target
Over the past 31 weeks, BNOX's average price target has gone down $3.33.
BNOX reports an average of 198.62% for its upside potential over the past 39 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-06-23 | 5 | 17 | 6 | 9.50 | 2.06 | 361.17% |
| 2023-09-28 | 5 | 17 | 6 | 9.50 | 3.37 | 181.9% |
| 2023-10-16 | 3 | 10 | 6 | 8.00 | 4.43 | 80.59% |
| 2023-10-16 | 4 | 17 | 6 | 10.25 | 4.43 | 131.38% |
| 2023-10-16 | 5 | 10 | 6 | 8.00 | 4.43 | 80.59% |
BNOX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 43 weeks, BNOX's average broker recommendation rating improved by 0.67.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BNOX as an investment opportunity.
- In the context of all US stocks, BIONOMICS LIMITED's upside potential (average analyst target price relative to current price) is greater than 1752.3% of them.
- BIONOMICS LIMITED's variance in analysts' estimates is lower than -1442.68% of all US stocks.
- In terms of how BIONOMICS LIMITED fares relative to stocks in the micro market cap category, note that its number of analysts covering the stock is greater than 1597.79% of that group.
- In terms of how BIONOMICS LIMITED fares relative to Healthcare stocks, note that its average analyst price target is higher than 498.2% of that group.
In the Pharmaceutical Products industry, NVCT, ACRV, and COYA are the three stocks most similar to BIONOMICS LIMITED regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is BNOX a Buy, Hold or Sell? See the POWR Ratings now!